Sorry Steelers fans, we're going to need to shake this one off. The Pittsburgh Steelers are now 1-1 two weeks into the 2025 regular season — and while there were a few bright spots in the loss to the ...

FOXBOROUGH, Massachusetts — The Browns need the bye week. They need more than that, but that's all they can get right now. Cleveland head into the bye week off one of their worst losses of the season, ...

Week 8's Friday night games of the Section 2 football season are complete. Some of tonight’s early finals… Advertisement Article continues below this ad Below the links and photo gallery, the Times ...

Billionaire Bill Gates predicts that advances in technology, particularly in artificial intelligence, will likely lead to a reduced two-day work week over the next decade, as it will replace humans on ...

RALEIGH, N.C. — A bill to keep funding North Carolina’s Medicaid program is now in the hands of the State Senate. The legislation passed its third reading in the House Wednesday. It would pull $190 ...

Fans at Lackawanna Trail and Riverside couldn’t ask for a better scenario. The two best teams in the Lackawanna Football Conference Division III will decide the champion in a Week 10 showdown at ...

The Cleveland Browns (2-5) visit the New England Patriots (5-2). See our bold predictions for the Week 8 matchup between AFC powers. The Cleveland Browns most recently took down the Miami Dolphins ...

ESPN's "College GameDay" is heading to Nashville for the first time since 2008 in Week 9. "GameDay" will be on site for No. 12 Vanderbilt vs. No. 14 Missouri, a top-15 matchup between SEC programs ...

Sports products & strategy vice president Brian Marshall during ESPN's 2025 Direct to Consumer Press Event. (Photo by Phil Ellsworth / ESPN Images) Disney is warning YouTube TV subscribers that they ...

Daniel Jones looks to keep rolling against the Titans, Bo Nix goes hot streak hunting against the Cowboys’ burnable defense, and Jaxson Dart attempts to make it two QB1 performances against the Eagles ...

Ventyx Biosciences’ cardiovascular disease drug cut levels of a biomarker for stroke and other serious risks by almost 80% within a week. The San Diego-based biotech has been evaluating the oral NLRP3 ...